A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults

Clinical trial NCT03758612 · COMPLETED

Trial details

NCT number: NCT03758612
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Tuberculosis Tuberculosis, Pulmonary

Start date: 2019-01-16
Primary completion: 2020-03-15
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.